|Bid||13.00 x 3100|
|Ask||13.70 x 1400|
|Day's Range||13.09 - 13.55|
|52 Week Range||8.37 - 19.34|
|Beta (5Y Monthly)||1.52|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 07, 2022 - Nov 11, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||24.08|
PARSIPPANY, N.J., August 10, 2022--Pravin U. Dugel, M.D., President, will participate in a panel discussion at the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference.
PARSIPPANY, N.J., August 03, 2022--Iveric Bio announced the Company will participate in a fireside chat at the Wedbush PacGrow Healthcare Conference 2022 on Tuesday, August 9, 2022.
PARSIPPANY, N.J., August 02, 2022--Iveric Bio granted equity-based awards pursuant to the Company’s 2019 Inducement Stock Incentive Plan to two newly-hired, non-executive employees.